反応式
[CH3:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[N:10]=[CH:9][CH:8]=[C:7]2[N:12]1[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]1.C(N(CC)CC)C.[C:25](Cl)(=[O:30])/[CH:26]=[CH:27]/[CH2:28][CH3:29]>ClCCl>[CH3:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[N:10]=[CH:9][CH:8]=[C:7]2[N:12]1[CH2:17][CH2:16][N:15]([C:25](=[O:30])/[CH:26]=[CH:27]/[CH2:28][CH3:29])[CH2:14][CH2:13]1参加物
5
実験手順
8-Methyl-4-piperazin-1-yl-quinoline (22.7 mg, 0.1 mmol) was dissolved in dichloromethane (1 ml), triethylamine was added (1 ml of a 0.12 M solution in dichloromethane) followed by a solution of (E)-pent-2-enoyl chloride (1 ml, 0.12 M in dichloromethane). The mixture was shaken briefly, washed with 5% sodium bicarbonate solution (2×), water and evaporated to dryness. The raw product was purified by preparative HPLC (gradient of water containing 0.1% ammonia and acetonitrile) to yield 2.8 mg of a solid (0.009 mmol, 9%).
後処理
- washwashed with 5% sodium bicarbonate solution (2×), water
- customevaporated to dryness
- customThe raw product was purified by preparative HPLC (gradient of water containing 0.1% ammonia and acetonitrile)
出典と根拠
- ORDレコード
- ord-bfcfd5a66fe44642ba71d6f63e70577d
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08883791B2
関連ノート
読み込み中…